Literature DB >> 23963788

Epigenetics and the modulation of neuroinflammation.

Gwenn A Garden1.   

Abstract

Innate immune responses in the central nervous system (CNS) have key roles influencing both physiological and pathological processes. Microglia are innate immune effector cells that reside within the CNS. These inflammatory cells are constantly surveying their external environment and rapidly respond to a variety of molecules that signal changes in CNS homeostasis. In response to these signals, microglia influence neuronal connections, modulate the functions of other glia, and mediate inflammatory responses to disease or injury. In parallel with the regulation of inflammatory responses outside of the CNS, investigators have observed that microglia are capable of heterogeneous responses to exogenous and endogenous signals. While much of this molecular and morphological heterogeneity is regulated by gene transcription, there is ample evidence that microglial behavior is determined, in part, by epigenetic regulation. Recent work has demonstrated that processes involving DNA methylation, histone modification, and noncoding RNAs also have important roles in modulating neuroinflammation. Here I will review the evidence supporting a role for epigenetic regulation of neuroinflammation and describe how this might influence the outcome of several CNS disorders, including addiction, infection, multiple sclerosis, and stroke.

Entities:  

Mesh:

Year:  2013        PMID: 23963788      PMCID: PMC3805872          DOI: 10.1007/s13311-013-0207-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  54 in total

1.  S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.

Authors:  Hung-Chi Lin; Huei-Min Hsieh; Yu-Hsuan Chen; Miao-Lin Hu
Journal:  Neurotoxicology       Date:  2009-04-08       Impact factor: 4.294

2.  Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.

Authors:  Yuan Yuan Li; Jian Guo Cui; Prerna Dua; Aileen I Pogue; Surjyadipta Bhattacharjee; Walter J Lukiw
Journal:  Neurosci Lett       Date:  2011-05-26       Impact factor: 3.046

Review 3.  Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases.

Authors:  Stephen J Shuttleworth; Sarah G Bailey; Paul A Townsend
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 4.  The therapeutic potential of HDAC inhibitors in the treatment of multiple sclerosis.

Authors:  Giuseppe Faraco; Leonardo Cavone; Alberto Chiarugi
Journal:  Mol Med       Date:  2011-02-25       Impact factor: 6.354

5.  MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway.

Authors:  Eugene D Ponomarev; Tatyana Veremeyko; Natasha Barteneva; Anna M Krichevsky; Howard L Weiner
Journal:  Nat Med       Date:  2010-12-05       Impact factor: 53.440

6.  Fate mapping analysis reveals that adult microglia derive from primitive macrophages.

Authors:  Florent Ginhoux; Melanie Greter; Marylene Leboeuf; Sayan Nandi; Peter See; Solen Gokhan; Mark F Mehler; Simon J Conway; Lai Guan Ng; E Richard Stanley; Igor M Samokhvalov; Miriam Merad
Journal:  Science       Date:  2010-10-21       Impact factor: 47.728

7.  Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes.

Authors:  Hyeon-Sook Suh; Shinyeop Choi; Pallavi Khattar; Namjong Choi; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2010-02-17       Impact factor: 4.147

8.  Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.

Authors:  Na'ama A Shein; Nikolaos Grigoriadis; Alexander G Alexandrovich; Constantina Simeonidou; Athanasios Lourbopoulos; Eleni Polyzoidou; Victoria Trembovler; Paolo Mascagni; Charles A Dinarello; Esther Shohami
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

9.  Epigenetic and inflammatory marker profiles associated with depression in a community-based epidemiologic sample.

Authors:  M Uddin; K C Koenen; A E Aiello; D E Wildman; R de los Santos; S Galea
Journal:  Psychol Med       Date:  2010-09-14       Impact factor: 7.723

10.  Presenilin 2 is the predominant γ-secretase in microglia and modulates cytokine release.

Authors:  Suman Jayadev; Amanda Case; Alison J Eastman; Huy Nguyen; Julia Pollak; Jesse C Wiley; Thomas Möller; Richard S Morrison; Gwenn A Garden
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

View more
  24 in total

1.  Looking above but not beyond the genome for therapeutics in neurology and psychiatry: epigenetic proteins and RNAs find a new focus.

Authors:  Manuela Basso; Sama Sleiman; Rajiv R Ratan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

2.  Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake.

Authors:  A M Gómez-Uriz; E Goyenechea; J Campión; A de Arce; M T Martinez; B Puchau; F I Milagro; I Abete; J A Martínez; A Lopez de Munain
Journal:  J Physiol Biochem       Date:  2014-02-07       Impact factor: 4.158

3.  Local Cues Establish and Maintain Region-Specific Phenotypes of Basal Ganglia Microglia.

Authors:  Lindsay M De Biase; Kornel E Schuebel; Zachary H Fusfeld; Kamwing Jair; Isobel A Hawes; Raffaello Cimbro; Hai-Ying Zhang; Qing-Rong Liu; Hui Shen; Zheng-Xiong Xi; David Goldman; Antonello Bonci
Journal:  Neuron       Date:  2017-07-06       Impact factor: 17.173

Review 4.  Microglia: Driving critical periods and sexual differentiation of the brain.

Authors:  Jonathan W VanRyzin; Lindsay A Pickett; Margaret M McCarthy
Journal:  Dev Neurobiol       Date:  2018-01-03       Impact factor: 3.964

Review 5.  Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors:  Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal:  Metab Brain Dis       Date:  2021-08-13       Impact factor: 3.584

6.  DNA methylation modifications associated with chronic fatigue syndrome.

Authors:  Wilfred C de Vega; Suzanne D Vernon; Patrick O McGowan
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

7.  Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells.

Authors:  Joanna Ślusarczyk; Ewa Trojan; Katarzyna Głombik; Bogusława Budziszewska; Marta Kubera; Władysław Lasoń; Katarzyna Popiołek-Barczyk; Joanna Mika; Krzysztof Wędzony; Agnieszka Basta-Kaim
Journal:  Front Cell Neurosci       Date:  2015-03-12       Impact factor: 5.505

Review 8.  The interplay of early-life stress, nutrition, and immune activation programs adult hippocampal structure and function.

Authors:  Lianne Hoeijmakers; Paul J Lucassen; Aniko Korosi
Journal:  Front Mol Neurosci       Date:  2015-01-09       Impact factor: 5.639

Review 9.  Microglial Priming and Alzheimer's Disease: A Possible Role for (Early) Immune Challenges and Epigenetics?

Authors:  Lianne Hoeijmakers; Yvonne Heinen; Anne-Marie van Dam; Paul J Lucassen; Aniko Korosi
Journal:  Front Hum Neurosci       Date:  2016-08-09       Impact factor: 3.169

10.  Chronic Noise Exposure Acts Cumulatively to Exacerbate Alzheimer's Disease-Like Amyloid-β Pathology and Neuroinflammation in the Rat Hippocampus.

Authors:  Bo Cui; Kang Li; Zhihui Gai; Xiaojun She; Na Zhang; Chuanxiang Xu; Xuewei Chen; Gaihong An; Qiang Ma; Rui Wang
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.